Back

Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Inflammatory and Infectious Disorders and Heart Disease HIV and Cardiovascular Disease ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Miguel Frias

University hospitals of Geneva, Geneva (Switzerland)

5 More presentations in this session

Presentation thumbnail
Genetically rheumatoid arthrits and risk of comorbidities: a Mendelian randomization study
Ms A. Fokina (Vienna, AT)
Abstract Slides
Presentation thumbnail
Predictors of subclinical right ventricular dysfunction and pulmonary hypertension in asymptomatic patients with pulmonary sarcoidosis
Doctor I. Evsikova (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Survey of cardiovascular disease and risk factor management in patients with rheumatoid arthritis across 5 world regions: Results from the SURF-RA
Assistant Professor A. Semb (Oslo, NO)
Abstract Slides
Presentation thumbnail
Can quantitative 18F-FDG PET/CT and serum cytokine analysis differentiate ARVC from cardiac sarcoidosis?
Doctor H. Abbas (Aberdeen, GB)
Abstract Slides
Presentation thumbnail
The systemic immune-inflammation index is associated with early postoperative morbidity and mortality following cardiac surgery
Doctor R. Rosalia (Skopje, MK)
Abstract Slides

Access the full session

Session thumbnail
Inflammatory and Infectious Disorders and Heart Disease

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources